Cenestin
Company: Duramed Pharmaceuticals
Approval Status: Approved July 1999
Treatment for: Obstetrics/Gynecology
Areas: Neurology; Obstetrics/Gynecology
Possible similar drugs: Cenestin
| General Information | Side Effects |
General Information
Cenestin has been approved for the treatment of hot flashes, night sweats, and other moderate-to-severe vasomotor symptoms associated with menopause. Cenestin is a slow-release conjugated estrogen product that is synthesized 100% from soy and yam plants. Premarin, the only other slow-release conjugated estrogen product, is derived from pregnant horses.
Side Effects
In clinical trials, the most frequently reported adverse events were headache and insomnia, which occurred with similar frequency in the placebo group. Pregnant women should not use hormone replacement therapy because of possible risk to the fetus.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
